ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: cardiovascular disease

Sugary Soft Drinks Can Raise Risk of Rheumatoid Arthritis

Richard Quinn  |  November 21, 2014

Study finds consuming one or more sugar-sweetened sodas daily can increase women’s chance of developing seropositive RA by more than 60%

Filed under:ConditionsResearch RheumRheumatoid Arthritis Tagged with:Rheumatoid arthritisrisk

How Wars Have Shaped Rheumatology

Simon M. Helfgott, MD  |  November 1, 2014

Treating sick, injured soldiers has taught physicians lessons about fighting infections, cancer

Filed under:OpinionRheuminationsSpeak Out Rheum Tagged with:CancerHelfgottHistoryReactive arthritisrheumatologistrheumatologyTreatment

Inflammatory Origin of Fever Is Key to Diagnosis

Simon M. Helfgott, MD  |  September 1, 2014

Fever in rheumatology patients may present evidence of an inflammatory process

Filed under:ConditionsGout and Crystalline ArthritisOpinionOther Rheumatic ConditionsRheuminationsSpeak Out RheumSystemic Lupus Erythematosus Tagged with:braincrystal arthritisfeverGoutHelfgottimagingInfectioninflammatorymicrobepatient carerheumatologistSarcoidosisSystemic lupus erythematosus

Drugs Studied for Use in Rheumatoid Arthritis, Weight Loss

Michele B. Kaufman, PharmD, BCGP  |  August 1, 2014

Plus, rheumatology drug news from EULAR 2014

Filed under:Axial SpondyloarthritisConditionsDrug UpdatesEULAR/OtherMeeting ReportsPsoriatic ArthritisRheumatoid Arthritis Tagged with:AC&RAmerican College of Rheumatology (ACR)Ankylosing Spondylitisanti-inflammatorydrugEULARInternationalKaufmanMethotrexatepsoriatic arthritisRheumatoid arthritisrheumatologistrheumatologySafetytocilizumabweight loss

EULAR 2014: Research on Rheumatoid Arthritis, Spondyloarthritis

Thomas R. Collins  |  August 1, 2014

Latest findings on rheumatological drug therapies, including methotrexate for RA, tumor necrosis factor inhibitors for SpA

Filed under:Axial SpondyloarthritisBiologics/DMARDsConditionsDrug UpdatesEULAR/OtherMeeting ReportsResearch RheumRheumatoid Arthritis Tagged with:Ankylosing Spondylitisanti-inflammatoryBiologicsCollinsdrugEULARGlucocorticoidsinfliximabInternationalMethotrexateResearchRheumatoid arthritisrheumatologySafety

What’s New in Inflammatory Arthritis?

Thomas R. Collins  |  June 1, 2014

Rheumatology experts at the ACR’s State-of-the-Art Clinical Symposium in Chicago discuss latest drug therapies, insights into axial spondyloarthritis and bone erosion, repair

Filed under:Axial SpondyloarthritisBiologics/DMARDsConditionsDrug UpdatesRheumatoid Arthritis Tagged with:AC&RadalimumabAmerican College of Rheumatology (ACR)BiosimilarsCollinsdruginfliximabMethotrexateradiographRheumatoid arthritistocilizumab

Case Study in Dermatology: Familial Sarcoidosis/Blau Syndrome

Johanna Sheu, MS, & Joseph F. Merola, MD, MMSc  |  June 1, 2014

Test your diagnostic knowledge with this case of multiple erythematous, slightly hyperpigmented waxy papules coalescing into plaques without scale over both distal lower extremities

Filed under:ConditionsRheumatoid ArthritisSystemic Lupus ErythematosusVasculitis Tagged with:autoinflammatoryDermatologyRheumatoid arthritisrheumatologistSarcoidosisSystemic lupus erythematosusVasculitis

Why Tweaking Molecular Structures Can Be Hazardous to Our Health

Simon M. Helfgott, MD  |  June 1, 2014

The rise and fall of rofecoxib and valdecoxib demonstrate the need for caution in new drug development

Filed under:Biologics/DMARDsDrug UpdatesOpinionResearch RheumRheuminationsSpeak Out Rheum Tagged with:anti-inflammatoryBiosimilarsdrugHelfgottpatient careResearchrheumatologistrofecoxib

Recipients of Ephraim P. Engleman Endowed Resident Research Preceptorship Award in Rheumatology Meet Physician Who Helped Shape Their Careers

From the College  |  May 1, 2014

Award’s namesake, 103-year-old rheumatologist Ephraim P. Engleman, MD, met 10 winners of research funding established in his name by the Rheumatology Research Foundation in 2006

Filed under:ConditionsFrom the CollegeProfessional TopicsProfilesResearch RheumRheumatoid Arthritis Tagged with:AC&RACR/ARHP Annual MeetingAmerican College of Rheumatology (ACR)AwardsBiologicsdrugMethotrexateProfileRheumatoid arthritisrheumatologistRheumatology Research Foundation

Mobile Health Devices May Have Limited Use in Rheumatology

Simon M. Helfgott, MD  |  April 2, 2014

Challenges exist in developing m-health apps for rheumatology patients because of the difficulty in pinpointing what needs to be measured

Filed under:AppsOpinionPractice SupportQuality Assurance/ImprovementRheuminationsSpeak Out RheumTechnology Tagged with:appsHelfgottpatient carePractice ManagementrheumatologistTechnology

  • « Previous Page
  • 1
  • …
  • 57
  • 58
  • 59
  • 60
  • 61
  • …
  • 66
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2026 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences